The research, involving rodents, offers proof that contact with EM waves, as it is related to mobile phone use could safeguard and even change Alzheimer’s disease. The researchers discovered that subjecting mice with Alzheimer’s disease to EM waves produced by mobile phones decreased brain deposits. The deposits are made up of a protein formation known as beta-amyloid. Brain areas created by the unusual build up of the protein are foundations of this disease. This is why the majority of remedies attempt to focus on protein. The researchers isolated the results of the contact with the EM waves to the rodents from other activities, such as physical exercise and eating habits.

In the investigation, ninety six rodents were examined. The group consisted of mice that had Alzheimer’s disease as well as those that didn’t have it. Both the mice that had Alzheimer’s and the regular rodents had been subjected to the EM field produced by regular cellular use for 2 hours for every day for 7-9 months. Now unlike people, the mice couldn’t wear headsets or earphones. The cages they were in were set up around a main antenna producing the mobile phone signal. The animals were then subjected to the EM waves.

The investigators state that if contact was started when the Alzheimer’s rodents were younger, and before it was obvious that they had lost their memory, their intellectual abilities would have been saved. When the mice with Alzheimers had been exposed to the EM waves, their memory got better. The improvements aren’t something that occurs overnight. The improvement takes a good while to see. It is however, something to do some further research on.

The investigators felt that the result of the studies could mean that exposure to the EM waves could was a new way to manage the disease in people as well as possibly healing other mental deterioration diseases. So far there has been no evidence that the exposure is dangerous to the average person; however more research will definitely need to be done to substantiate these claims.

A brand new imaging method that calculates the random movement of water inside the human brain might provide evidence helpful for discovering early indications of Alzheimer’s disease. This method, identified as diffusion tensor imaging (DTI) or diffusion MRI, can be used to help evaluate alterations within the white matter areas of the human brain. However it is significantly clear that DTI may also be utilized to discover microscopic structural alterations within the gray matter of the mind,that is crucial for learning and recollection.

Researchers have discovered that DTI checking forecasted declines in retention performance along with a great deal more accuracy and reliability as compared to a regular MRI. This kind of human brain check seems to be an improved method to calculate exactly how healthy the human brain is in those who are suffering from loss of memory. This may help physicians when they are trying to distinguish between regular aging and illnesses like Alzheimer’s.

MRI, DTI, and Alzheimer’s

In their investigation, researchers recruited 76 people that were healthy. These seventy-six individuals were in the ages between twenty and eighty. These people conducted DTI checking of the hippocampus. This is the area of the human brain that handles retention. Additionally they implemented regular MRI checking to evaluate the entire volume of the hippocampus and they also ran a battery of tests that assessed memory functionality in each individual.

The investigators discovered that DTI checking was able to better forecast memory functionality than measurement of hippocampus volume, particularly individuals greater than 50 years old. In spite of the results that were found with these studies, more research will need to be performed to show that DTI scanning really forecasts Alzheimer’s condition in individuals who haven’t yet proven distinct memory impairment. It is understood within the medical field that any medicinal treatment options for Alzheimer’s disease must start as soon as possible. In order for this to happen, it is important to find individuals that are at a high risk to have the disease as early as possible.

Alzheimer’s disease Diagnosis Continues to be a Concern

A huge concern in the medical field these days is the identification of Alzheimer’s disease as well as other types of dementia. A good medical exam and complete analysis is still one of the best ways that exists to diagnose this disease. MRI scans have been used and they definitely can tell if the hippocampus volume is smaller than it should be, but it still can’t help show doctors what is causing the disease. The DTI scan is proving that it is becoming a good imaging method that might be more useful for diagnosing and predicting or forecasting the beginning of the disease.

Positron tomography (PET) checking coupled with a new brain-imaging agent known as Pittsburgh Compound B exhibits hope for discovering the irregular human brain proteins, referred to as amyloid plaques, that characterize Alzheimer’s disease. High-resolution MRI additionally exhibits proof being more sensitive than conventional way of measuring of hippocampus volume for evaluating memory impairment. It is hoped that within the decade, physicians are going to be significantly better at recognizing those that might develop Alzheimer’s disease before the symptoms start.

The so-called “long life gene” might accomplish a lot more than increase years to your existence. It might additionally help stave off age-related cognitive decrease, and this particular finding is making the path for brand new medications to address Alzheimer’s disease, research shows.

The long life gene is a version of the cholesteryl ester transfer protein (CETP) gene that was discovered in 2003. This version can increase levels of cholesterol through raising “good” cholesterol and managing the size of cholesterol pieces. Due to this, it has been associated with long life and reduced cardiovascular disease danger, but exactly how or if this type of version has an effect on the cognitive decline that may occur with getting older has not been recognized until now.

Investigators examined the blood of five hundred and twenty-three individuals that were older than sixty-nine years of age. These individuals showed no sign of any intellectual decrease. They were looking to see what type of the CETP gene these people maintained. Individuals in the analysis also underwent standard brain assessments every year between the years of 1994 and the year 2009. The evaluations were processed to assess memory, focus span, and process time.

During 4.3 years of follow-up, there have been forty new cases of mental deterioration observed amongst this group of individuals. Those individuals that had a certain variation of the CETP gene had been not as likely to encounter a decrease in memory and also to acquire mental deterioration.

It turns out that the people in the study group that had 2 copies of the variation gene had a seventy percent decrease in their chance to be a victim of Alzheimer’s disease in contrast to individuals who had no copies of this gene variant. This version shifts the gene so that the protein it encodes for function much less effectively than usual. Now, medications are now being created that copy this result.